Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 21009 | 376 | 39.0 | 93% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 348 | 16958 | DNA METHYLATION//EPIGENETICS//HISTONE DEACETYLASE INHIBITOR |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | DAP KINASE | Author keyword | 46 | 74% | 9% | 34 |
| 2 | DEATH ASSOCIATED PROTEIN KINASE | Author keyword | 41 | 68% | 10% | 36 |
| 3 | DAPK | Author keyword | 31 | 54% | 11% | 40 |
| 4 | DAPK1 | Author keyword | 16 | 58% | 5% | 18 |
| 5 | CHRONIC OBSTRUCTIVE UROPATHY | Author keyword | 4 | 67% | 1% | 4 |
| 6 | DAPK 1 | Author keyword | 4 | 75% | 1% | 3 |
| 7 | DRAK2 | Author keyword | 4 | 75% | 1% | 3 |
| 8 | CELLULAR INTEGRATED PHYSIOL | Address | 3 | 60% | 1% | 3 |
| 9 | DAPK GENE | Author keyword | 3 | 60% | 1% | 3 |
| 10 | DAPK2 | Author keyword | 3 | 60% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | DAP KINASE | 46 | 74% | 9% | 34 | Search DAP+KINASE | Search DAP+KINASE |
| 2 | DEATH ASSOCIATED PROTEIN KINASE | 41 | 68% | 10% | 36 | Search DEATH+ASSOCIATED+PROTEIN+KINASE | Search DEATH+ASSOCIATED+PROTEIN+KINASE |
| 3 | DAPK | 31 | 54% | 11% | 40 | Search DAPK | Search DAPK |
| 4 | DAPK1 | 16 | 58% | 5% | 18 | Search DAPK1 | Search DAPK1 |
| 5 | CHRONIC OBSTRUCTIVE UROPATHY | 4 | 67% | 1% | 4 | Search CHRONIC+OBSTRUCTIVE+UROPATHY | Search CHRONIC+OBSTRUCTIVE+UROPATHY |
| 6 | DAPK 1 | 4 | 75% | 1% | 3 | Search DAPK+1 | Search DAPK+1 |
| 7 | DRAK2 | 4 | 75% | 1% | 3 | Search DRAK2 | Search DRAK2 |
| 8 | DAPK GENE | 3 | 60% | 1% | 3 | Search DAPK+GENE | Search DAPK+GENE |
| 9 | DAPK2 | 3 | 60% | 1% | 3 | Search DAPK2 | Search DAPK2 |
| 10 | DLK ZIP KINASE | 3 | 60% | 1% | 3 | Search DLK+ZIP+KINASE | Search DLK+ZIP+KINASE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | DAP KINASE | 57 | 40% | 29% | 110 |
| 2 | ZIP KINASE | 16 | 54% | 5% | 20 |
| 3 | TUMOR SUPPRESSOR DAPK | 14 | 100% | 2% | 7 |
| 4 | APOPTOTIC CHECKPOINT | 8 | 70% | 2% | 7 |
| 5 | PROTEIN KINASE DAPK | 7 | 64% | 2% | 7 |
| 6 | DLK ZIP KINASE | 6 | 41% | 3% | 11 |
| 7 | DEATH ASSOCIATED PROTEIN KINASE 2 | 4 | 75% | 1% | 3 |
| 8 | DAPK | 3 | 43% | 2% | 6 |
| 9 | HYPERMETHYLATED GENES | 3 | 60% | 1% | 3 |
| 10 | DAP LIKE KINASE | 2 | 67% | 1% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The death-associated protein kinases: Structure, function, and beyond | 2006 | 188 | 84 | 54% |
| Death-associated protein kinase (DAPK) and signal transduction: regulation in cancer | 2010 | 41 | 50 | 54% |
| Death-associated protein kinase (DAPK) and signal transduction: additional roles beyond cell death | 2010 | 38 | 72 | 53% |
| DAPk protein family and cancer | 2006 | 98 | 71 | 52% |
| Death Associated Protein Kinases: Molecular Structure and Brain Injury | 2013 | 3 | 55 | 44% |
| Structural and functional diversity in the activity and regulation of DAPK-related protein kinases | 2013 | 5 | 83 | 28% |
| Aberrant DNA methylation in cervical carcinogenesis | 2013 | 6 | 52 | 23% |
| Programmed cell death: From novel gene discovery to studies on network connectivity and emerging biomedical implications | 2007 | 6 | 34 | 62% |
| Epigenetic alterations in cervical carcinogenesis | 2009 | 40 | 92 | 18% |
| Death-associated protein kinase: A molecule with functional antagonistic duality and a potential role in inflammatory bowel disease (Review) | 2015 | 0 | 102 | 53% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CELLULAR INTEGRATED PHYSIOL | 3 | 60% | 0.8% | 3 |
| 2 | CRUK SIGNAL TRANSDUCT S P53 | 2 | 67% | 0.5% | 2 |
| 3 | GENET EXP S CONTROL | 1 | 100% | 0.5% | 2 |
| 4 | GENE EXP S CONTROL | 1 | 30% | 0.8% | 3 |
| 5 | EXPT TUMOR PATHOL | 1 | 40% | 0.5% | 2 |
| 6 | BIOMASS VALORIZAT PROT PROD EUKARYOTES | 1 | 50% | 0.3% | 1 |
| 7 | BS MD PROGRAM | 1 | 50% | 0.3% | 1 |
| 8 | CANC UK P53 SIGNAL TRANSDUCT GRP | 1 | 50% | 0.3% | 1 |
| 9 | CELL SIGNALLING UNITCRUK P53 SIGNAL TRANSDUCT GR | 1 | 50% | 0.3% | 1 |
| 10 | HOSP MONCORVO FILHO | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000261765 | PAR 4//AATF//PROSTATE APOPTOSIS RESPONSE 4 |
| 2 | 0.0000233078 | RASSF1A//RASSF2//RASSF1 |
| 3 | 0.0000130705 | CHFR//EPIGENETCANC//P41 ARC |
| 4 | 0.0000090691 | RRBS//CPG ISLANDS//METHYLTRANSFERASE ACTIVITY |
| 5 | 0.0000079644 | ZEBULARINE//DECITABINE//FAZARABINE |
| 6 | 0.0000059006 | P16INK4A//L1 CAPSID PROTEIN//PROEX C |
| 7 | 0.0000057493 | DAP3//ICT1//MITOCHONDRIAL RIBOSOMAL PROTEINS |
| 8 | 0.0000045112 | STE20 LIKE KINASE//MAP4K4//STE20 |
| 9 | 0.0000045054 | P14ARF//P16//P16INK4A |
| 10 | 0.0000038662 | DNMT3B//DNA METHYLTRANSFERASE//DNMT1 |